Wintjens, Anne G. W. E.
Liu, Hong
Fransen, Peter-Paul K.H.
Lenaerts, Kaatje
van Almen, Geert C.
Gijbels, Marion J.
Hadfoune, M’hamed
Boonen, Bas T.C.
Lieuwes, Natasja G.
Biemans, Rianne
Dubois, Ludwig J.
Dankers, Patricia Y.W.
de Hingh, Ignace H.J.T.
Bouvy, Nicole D.
Funding for this research was provided by:
KWF Kankerbestrijding (12055, 12055, 12055)
Article History
Received: 13 January 2023
Accepted: 8 May 2023
First Online: 22 May 2023
Statements and disclosures
: The authors acknowledge the funding of the Dutch Cancer Society (project number 12055) and the support of the partners of Regenerative Medicine Crossing Borders (RegMed XB), powered by Health ~ Holland, Top Sector Life Sciences & Health and the Dutch Ministry of Education, Culture and Science for the Gravitation Programs (024.003.013 and 024.005.020). Patricia Dankers, Peter-Paul Fransen, and Geert van Almen are co-founders and hold shares of UPy-Ther BV. Ignace de Hingh receives an unrestricted research funding from Rand and ROCHE, both paid to the institute (Maastricht University).